Physician profile
Barry Cohen
NPI 1275527707
$5,418.81
in general payments reported to CMS, 2019-2025
47 companies · $1,024 in 2025
The $1,024 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,058 · 2020: $278 · 2021: $515 · 2022: $1,050 · 2023: $676 · 2024: $819 · 2025: $1,024.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,519.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,518.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $706.80 | 2019-2025 | Sapien 3 Ultra Resilia |
| Amgen INC. | $632.71 | 2019-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $415.90 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $319.97 | 2021-2025 | Verquvo, Capvaxive |
| Amarin Pharma, INC. | $310.63 | 2019-2023 | |
| Novo Nordisk INC | $280.27 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
| Boston Scientific Corporation | $229.17 | 2019-2024 | Watchman Flx |
| Pfizer INC. | $219.60 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $218.29 | 2019-2025 | Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $149.52 | 2021-2025 | Jardiance |
| Medtronic, INC. | $141.48 | 2021-2024 | Corevalve Evolut R |
| Abbott Laboratories | $132.15 | 2019-2025 | Cardiomems |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $126.68 | 2019-2024 | Lifevest |
| Janssen Pharmaceuticals, INC | $119.45 | 2019-2023 | Xarelto |
| Regeneron Healthcare Solutions, INC. | $91.69 | 2019-2025 | Evkeeza |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barry Cohen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.